ESSA Pharma Inc (EPIX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 11.19M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 7.88
52W Low
$ 0.22
Dividend Yield
87.56%
Beta
1.56
Technicals
50-Day MA
1.6269
200-Day MA
1.6762
52 Week High
7.88
52 Week Low
0.2222
About EPIX
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
Employees
35
Headquarters
Vancouver, BC
CEO
Dr. David Ross Parkinson M.D.
Latest News
$EPIX stock is down 60% today. Here's what we see in our data. - Quiver Quantitative
2 weeks ago • Google News